is tirzepatide a diabetic drug Mounjaro (tirzepatide): Dual-Action Diabetes and Weight-Loss Medication Explained FDA approves new version of

Typical GLP-1 medication criteria include BMI 30 or greater, or BMI 27 or greater with qualifying conditions

Ozempic (semaglutide), off-label for weight loss

Large Observational Study Finds No Increased Pancreatitis Risk With GLP-1 RAs Presented at the American Heart Association Scientific Sessions 2025, the study showed that GLP-1 RAs do not increase the risk of pancreatitis

Common errors include injecting repeatedly in the same spot, incorrect depth, reusing needles, and not holding the pen in place long enough after injection

Take our free assessment quiz to connect with a licensed provider and begin your personalized journey toward lasting metabolic health